argenx SE (ARGX) Comparison with companies in other sectors?

argenx SE has a share price of 61.20M. You can analyze argenx SE (ARGX) competitors across different market sectors through stock heatmaps.

What are ARGX's NET and operating margins?

argenx SE (ARGX) operating margin is around 0.08, and net profit margin is approximately 0.41 as of the latest reports.

In what way does ARGX's earnings per share (EPS) trend reflect its financial momentum?

argenx SE (ARGX) EPS is 16.39 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for argenx SE is 34.22, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for argenx SE?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for argenx SE like P/E which is 32.11, P/B which is 6.23, and PEG which is 0.99. Compare them with sector averages to evaluate if the stock is priced fairly.

argenx SE

ARGX•NASDAQ

Healthcare

Biotechnology

$560.24

$-3.07(-0.54%)

Fundamental Analysis of argenx SE (ARGX)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$16.39

P/E Ratio

34.22

ROE

0.23%

Net Margin

0.41%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$34.33B

Shares OutstandingTotal number of shares issued

$61.20M

Book Value/ShareNet worth per share

$90.16

Revenue/ShareAnnual revenue per share

$42.31

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$16.39

Net MarginNet income as percentage of revenue

41.32%

Operating MarginOperating income as percentage of revenue

8.17%

ROEReturn on shareholders' equity

23.08%

ROAReturn on total assets

17.19%

ROCEReturn on capital employed

3.81%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-3.28

Cash/ShareCash and equivalents per share

$55.41

FCF YieldFree cash flow as percentage of market cap

-0.58%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for ARGXFinancial Ratios Analysis details for ARGX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ARGXSector Benchmarking details for ARGX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for argenx SE Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of argenx SE. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account argenx SE's unique business strengths and challenges.

Key Financial Metrics for argenx SE

For argenx SE, essential financial indicators include EPS 16.39, PE 34.22, and ROE 0.23. These key ratios reveal insights into argenx SE's profitability, valuation, and operational health. Understanding these metrics enables you to compare argenx SE with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of argenx SE

Metrics like Net Margin 41.32% and ROA 17.19% shed light on how well argenx SE is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether argenx SE can sustain its operations and continue growing in the future.

Valuation and Market Position of argenx SE

Using ratios such as P/B Ratio 6.23 and PEG Ratio 0.99, investors can assess whether argenx SE is appropriately valued based on its financials and growth potential. These figures, combined with argenx SE's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for argenx SE

Financial health indicators, such as Debt/Equity Ratio 0.007 and Cash Flow $-3.28, provide a snapshot of argenx SE's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like argenx SE, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for argenx SE

Investing in argenx SE based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at argenx SE focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;